Rahul R Aggarwal

42PUBLICATIONS
359CO-AUTHORS
Predictive and prognostic markersMolecular targetsToxicology (incl. clinical toxicology)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 20, 2026
Evaluation of an Artificial Intelligence Communication Platform for Racial Biases in Pretest Education About Prostate Cancer Germline Testing.

|Jun 01, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study.

|May 11, 2026
Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer.

|Feb 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Feb 13, 2026
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies.

Xiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu

|Jan 22, 2026
Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates.

Anil P Bidkar, Scott Bidlingmaier, Anju Wadhwa

Pageof 7

Frequent Collaborators

15 joint publications

Eric Small

9 joint publications

Felix Y Feng

7 joint publications

David Quigley

7 joint publications

Jonathan Chou